SEC and FDA Strengthen Cooperation with New MOU

The U. S. Securities and Exchange Commission (SEC) and the Food and Drug Administration (FDA) have entered into a Memorandum of Understanding (MOU) to enhance their cooperation and ensure market integrity. The agreement aims to facilitate the agencies' respective missions of protecting investors and ensuring the safety and efficacy of pharmaceuticals. The MOU will enable the SEC and FDA to share information and coordinate their efforts to address emerging issues and threats to market integrity. The agreement is designed to be flexible and adaptable to changing circumstances, allowing the agencies to respond effectively to new challenges.